Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma

NCT06069310 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chronic Rhinosinusitis With Nasal Polyps
Severe Eosinophilic Asthma
Chronic Rhinosinusitis Without Nasal Polyps

Interventions

DRUG: Mepolizumab 100 MG

Sponsor

National and Kapodistrian University of Athens